Skip to content

Insider · CIK 0001430462

Tamer I Khayal

officer

Files at TMDX (TransMedics Group, Inc.). First filing Nov 5, 2024, latest Mar 5, 2025.

In brief

Tamer I Khayal files SEC Form 4 as officer at TMDX (TransMedics Group, Inc.). Since Nov 5, 2024, Tamer I Khayal has reported 0 open-market buys worth $0 and 5 open-market sells worth $585k, the latest filed on Mar 5, 2025.

A track record needs three past buys with six months of prices behind them; Tamer I Khayal has 0, so none is measured yet.

The newest scored trade: sold $184k of TMDX on Mar 3, 2025, filed Mar 5, 2025, scored 27 (weak).

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $585k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TMDX: TransMedics Group, Inc.

TMDXOct 9, 2026 · close 77.87

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
27Weak
TMDXsell
TransMedics Group, Inc.
$184k
2,407 shares
-6%-
0Weak
TMDXsell10b5-1
TransMedics Group, Inc.
$87k
1,083 shares
-5%-
0Weak
TMDXsell10b5-1
TransMedics Group, Inc.
$94k
1,084 shares
-5%-
0Weak
TMDXsell 210b5-1
TransMedics Group, Inc.
$131k
1,458 shares
-7%-
0Weak
TMDXsell 210b5-1
TransMedics Group, Inc.
$89k
1,083 shares
-5%-

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Nov 1, 2024 TMDX
TransMedics Group, Inc.
7,625
0.02% of outstanding
$625kNov 1, 2024$911k

Transactions

Every row this insider has filed, 15 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 3, 2025TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock
-2,407$76.43$184k36,042Mar 5, 2025
Feb 24, 2025TMDX
TransMedics Group, Inc.
AGrant or award
Common Stock
+17,606$0.00$038,449Feb 26, 2025
Feb 24, 2025TMDX
TransMedics Group, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+26,499$0.00$026,499Feb 26, 2025
Jan 7, 2025TMDX
TransMedics Group, Inc.
MOption exercise
Common Stock10b5-1
+1,083$13.28$14k21,926Jan 10, 2025
Jan 7, 2025TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock10b5-1
-1,083$80.05$87k20,843Jan 10, 2025
Jan 7, 2025TMDX
TransMedics Group, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,083$0.00$015,167Jan 10, 2025
Dec 2, 2024TMDX
TransMedics Group, Inc.
MOption exercise
Common Stock10b5-1
+1,084$13.28$14k21,927Dec 4, 2024
Dec 2, 2024TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock10b5-1
-1,084$86.40$94k20,843Dec 4, 2024
Dec 2, 2024TMDX
TransMedics Group, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,084$0.00$016,250Dec 4, 2024
Nov 11, 2024TMDX
TransMedics Group, Inc.
MOption exercise
Common Stock10b5-1
+1,458$38.46$56k22,301Nov 13, 2024
Nov 11, 2024TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock10b5-1
-1,458$90.04$131k20,843Nov 13, 2024
Nov 11, 2024TMDX
TransMedics Group, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,458$0.00$05,834Nov 13, 2024
Nov 1, 2024TMDX
TransMedics Group, Inc.
MOption exercise
Common Stock10b5-1
+1,083$13.28$14k21,926Nov 5, 2024
Nov 1, 2024TMDX
TransMedics Group, Inc.
SOpen-market sale
Common Stock10b5-1
-1,083$82.64$89k20,843Nov 5, 2024
Nov 1, 2024TMDX
TransMedics Group, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-1,083$0.00$017,334Nov 5, 2024

Questions about Tamer I Khayal

Answered from the filings on this page, as of the latest one.

Is Tamer I Khayal buying or selling?

Not in the last 12 months. Tamer I Khayal's latest open-market trade on SEC Form 4 was sold $184k of TMDX on Mar 3, 2025.

How did Tamer I Khayal's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tamer I Khayal has 0.

Where does Tamer I Khayal file Form 4?

Tamer I Khayal has filed Form 4 at TMDX (TransMedics Group, Inc.) as Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Tamer I Khayal: insider trades and track record | InsiderTell